In this modern era, with the help of various advanced technologies, medical science has
overcome most of the health-related issues successfully. Though, some diseases still remain …

Neurodegenerative diseases, such as Alzheimer′ s disease and Parkinson′ s disease
represent a huge unmet medical need. The prevalence of both diseases is increasing, but …

Alzheimer's disease is a neurodegenerative condition leading to atrophy of the brain and
robbing nearly 5.8 million individuals in the United States age 65 and older of their cognitive …

Alzheimer's disease (AD) will affect around 115 million people worldwide by the year 2050.
It is associated with the accumulation of misfolded and aggregated proteins (β-amyloid and …

This review summarizes articles that have been reported in literature on liposome-based
strategies for effective drug delivery across the blood–brain barrier. Due to their unique …

Introduction: Development of drug delivery systems for brain delivery is one of the most
challenging research topics in pharmaceutical areas, mainly due to the presence of the …

Exosomes are cell-derived vesicles that act as carriers for proteins and nucleic acids, with
therapeutic potential and high biocompatibility. We propose a new concept of exosome-like …

Neurological diseases represent a medical, social, and economic problem of paramount
importance in developed countries. Although their etiology is generally known, developing …

The central nervous system (CNS) is vulnerable to pathologic processes that lead to the
development of neurodegenerative disorders like Alzheimer's, Parkinson's and Huntington's …

Alzheimer's disease is characterized by the accumulation and deposition of plaques of β-
amyloid (Aβ) peptide in the brain. Given its pivotal role, new therapies targeting Aβ are in …